BMS-986325 / BMS - LARVOL DELTA

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (clinicaltrials.gov) - P1 | N=25 | Completed | Sponsor: Bristol-Myers Squibb | Active, not recruiting ➔ Completed

Trial completion

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome (clinicaltrials.gov) - P1 | N=118 | Terminated | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Terminated; Insufficient enrollment

Trial termination • Sjogren's Syndrome • CRP • CXCL8 • IFNG • IL1B • IL6 • TNFA

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (clinicaltrials.gov) - P1 | N=24 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Active, not recruiting

Enrollment closed

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (clinicaltrials.gov) - P1 | N=24 | Recruiting | Sponsor: Bristol-Myers Squibb | Not yet recruiting ➔ Recruiting

Enrollment open

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (clinicaltrials.gov) - P1 | N=24 | Not yet recruiting | Sponsor: Bristol-Myers Squibb

New P1 trial